TL;DR: InMode News Sentiment Overview

Last Updated: Oct 03, 2025 (UTC)

News based Sentiment: MIXED | Importance Score: 6

Key Insights

October brought a mix of positive and negative developments for InMode, including analyst upgrades alongside price target reductions and a 'bearish' market sentiment. The upcoming Q3 earnings release is a key event that will likely shape the investment narrative for the coming months.

Latest News Analysis: InMode

Last Updated: Oct 03, 2025 (UTC)

InMode: Mixed Signals & Q3 Earnings Watch

Detailed Analysis

  • On October 1st and 2nd, 2025, Zacks Research upgraded InMode (NASDAQ:INMD) from a "strong sell" to a "hold" rating, signaling a shift in their outlook after a period of negative assessment – this could encourage more investors to take a closer look.
  • Institutional investors were also making moves in early October, with Cary Street Partners Financial LLC increasing their stake by 1.0%, adding 1,315 shares valued at $2,375,000, and Parallel Advisors LLC boosting their holdings by a significant 63.1%, acquiring 763 shares worth $28,000. These increases suggest growing confidence among institutional players.
  • Analysts presented a mixed view of InMode’s prospects; Barclays lowered its price target from $24.00 to $21.00 while maintaining an "overweight" rating on July 30th, while Canaccord Genuity Group and Needham & Company LLC both reaffirmed "hold" ratings with price targets of $15.00. The consensus rating remains "Hold" with an average price target of $18.04.
  • InMode’s stock showed a slight increase in value between October 1st and October 2nd, opening at $14.90 and rising to $15.28, resulting in a market capitalization increase from $941.83 million to $965.85 million. The P/E ratio also edged up from 6.03 to 6.19, and the beta remained stable at around 2.00-2.09.
  • Investors are awaiting InMode’s Third Quarter 2025 financial results, scheduled for release on Wednesday, October 29, 2025, before market open. The consensus EPS estimate is $0.32, with anticipated revenue of $88.05 million – these numbers will be crucial in determining the company’s trajectory.
  • October 2025 stock forecasts are optimistic, projecting a monthly trading range of $15.28 to $17.37 with an average of $16.55, representing a potential 13.25% increase from the previous month and a 17.05% return on investment. One forecast even suggests a potential rise to $35.88 (+139.17%) by the end of the month, though current sentiment is "Bearish" with a Fear & Greed Index of 39.
  • As of October 1, 2025, InMode Ltd. reported a total of 599 employees, indicating a stable workforce size.

The Investment Story: October saw a mixed bag for InMode, with analyst upgrades and institutional investment alongside cautious price target revisions and a 'bearish' market sentiment. The upcoming Q3 earnings release on October 29th will be a key catalyst for determining the company's direction.

What It Means for Investors: The varied analyst opinions and institutional activity suggest uncertainty surrounding InMode's near-term performance. While forecasts are optimistic, the 'bearish' sentiment and Fear & Greed Index indicate potential downside risk, making the Q3 earnings report particularly important for investors to assess.

Looking Ahead: Investors should closely monitor the Q3 earnings release on October 29th, paying attention to whether the company meets the consensus estimates of $0.32 EPS and $88.05 million in revenue. Further analyst updates and institutional investment trends will also be crucial indicators.

The Bottom Line: InMode presents a cautiously optimistic investment opportunity. While positive signals like analyst upgrades and institutional buying are encouraging, the 'bearish' sentiment and mixed analyst price targets necessitate a careful evaluation of the upcoming earnings report before making any investment decisions.

InMode Competitors News Sentiment Analysis

Compare news sentiment across the main stock and its key competitors based on recent market analysis.

CompanySentimentRecent HeadlineImportance
mixed InMode: Mixed Signals & Q3 Earnings Watch
6 /10
positive Abbott Labs: Strong Earnings & Upgrades Offset Legal Concerns
7 /10
positive Boston Scientific: Strong Outlook & Analyst Optimism
8 /10
mixed QuidelOrtho: Balancing Growth & Cost Cuts
6 /10
mixed Procept BioRobotics: Growth & Volatility in September
7 /10
mixed Artivion: Earnings Beat Amidst Insider Sales
7 /10

Note: Sentiment analysis is based on the most recent monthly news data. Importance scores range from 1-10, with higher scores indicating greater market relevance.

Important: News sentiment data is updated regularly and based on publicly available news sources. Sentiment scores and analysis represent algorithmic assessments of market sentiment. This information is for educational purposes only and should not be considered as investment advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.